CHAUVIE , Stephane

Monte Carlo simulation for external beam radiotherapy requires precise modeling of the treatment linear accelerator head and of the primary electron beam. Detailed modeling of medical accelerators is complex and could require proprietary data, and the production of an adequate sample of primary particles to simulate statistically significant...

FDG-PET/CT (PET) is now considered the standard imaging tool for Hodgkin Lymphoma (HL) staging and restaging. However a CT-detected residual mass at the end of therapy (EoT) is still a challenge for PET interpretation. The aim of our study was to improve the overall accuracy of EoT PET/CT by using a dynamic dual-point scanning at 60 and 120...

Lettre à l'éditeur ("European Journal of Nuclear Medicine and Molecular Imaging" 45(8) : 1463–1464https://link.springer.com/article/10.1007%2Fs00259-018-4005-4

International audience

International audience

Purpose To investigate the progression-free survival (PFS) of patients with advanced Hodgkin lymphoma (HL) after a risk-adapted treatment strategy that was based on a positive positron emission tomography scan performed after two doxorubicin, vinblastine, vincristine, and dacarbazine (ABVD) cycles (PET2). Patients and Methods Patients with...

International audience

PURPOSE 18 F-Fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) is currently the standard technique to define minimal residual disease (MRD) status outside the bone marrow (BM) in patients with multiple myeloma (MM). This study aimed to define criteria for PET complete metabolic response after therapy, jointly...